P. Emery, F. Breedveld, M. Dougados, J. Kalden, M. Schiff et al., Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide, Annals of the Rheumatic Diseases, vol.61, issue.4, pp.290-297, 2002.
DOI : 10.1136/ard.61.4.290

B. Fautrel, A. Constantin, J. Morel, O. Vittecoq, A. Cantagrel et al., Recommendations of??the??French Society for??Rheumatology. TNF?? antagonist therapy in??rheumatoid arthritis, Joint Bone Spine, vol.73, issue.4, pp.433-441, 2006.
DOI : 10.1016/j.jbspin.2006.04.001
URL : https://hal.archives-ouvertes.fr/hal-00465298

B. Combe, R. Landewe, C. Lukas, H. Bolosiu, F. Breedveld et al., EULAR recommendations for the management of early arthritis: report of a task force of the European Fautrel et al Ann Rheum Dis, R249 Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), pp.249-283, 2007.

C. Lukas, B. Combe, P. Ravaud, J. Sibilia, R. Landew et al., Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the ??tude et Suivi des Polyarthrites Indiff??Renci??es r??centes (Study and Followup of Early Undifferentiate, Arthritis & Rheumatism, vol.31, issue.7, pp.1804-1811, 2011.
DOI : 10.1002/art.30371

T. Pincus, A. Gibofsky, and M. Weinblatt, Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: Better treatments but a shortage of rheumatologists, Arthritis & Rheumatism, vol.17, issue.4, pp.851-854, 2002.
DOI : 10.1002/art.10202

C. Allaart, Y. Goekoop-ruiterman, J. De-vries-bouwstra, F. Breedveld, and B. Dijkmans, Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study, Clin Exp Rheumatol, vol.24, pp.77-82, 2006.

J. Fransen, H. Moens, I. Speyer, and P. Van-riel, Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial, Annals of the Rheumatic Diseases, vol.64, issue.9, pp.1294-1298, 2005.
DOI : 10.1136/ard.2004.030924

C. Grigor, H. Capell, A. Stirling, A. Mcmahon, P. Lock et al., Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial, The Lancet, vol.364, issue.9430, pp.263-269, 2004.
DOI : 10.1016/S0140-6736(04)16676-2

J. Smolen, D. Aletaha, J. Bijlsma, F. Breedveld, D. Boumpas et al., Treating rheumatoid arthritis to target: recommendations of an international task force, Annals of the Rheumatic Diseases, vol.69, issue.4, pp.631-637, 2010.
DOI : 10.1136/ard.2009.123919

B. Svensson, C. Schaufelberger, A. Teleman, and J. Theander, Remission and response to early treatment of RA assessed by the Disease Activity Score, Rheumatology, vol.39, issue.9, pp.1031-1036, 2000.
DOI : 10.1093/rheumatology/39.9.1031

S. Van-der-kooij, J. De-vries-bouwstra, Y. Goekoop-ruiterman, D. Van-zeben, P. Kerstens et al., Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score, Annals of the Rheumatic Diseases, vol.66, issue.10, pp.1356-1362, 2007.
DOI : 10.1136/ard.2006.066662

S. Van-der-kooij, S. Le-cessie, Y. Goekoop-ruiterman, J. De-vries-bouwstra, D. Van-zeben et al., Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.68, issue.7, pp.1153-1158, 2009.
DOI : 10.1136/ard.2008.093294

C. Escalas, M. Dalichampt, B. Combe, B. Fautrel, F. Guillemin et al., Effect of adherence to European treatment recommendations on early arthritis outcome: data from the ESPOIR cohort, Annals of the Rheumatic Diseases, vol.71, issue.11, pp.1803-1808, 2012.
DOI : 10.1136/annrheumdis-2011-200761
URL : https://hal.archives-ouvertes.fr/hal-00790231

L. Loet, X. Berthelot, J. Cantagrel, A. Combe, B. et al., Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology, Annals of the Rheumatic Diseases, vol.65, issue.1, pp.45-50, 2006.
DOI : 10.1136/ard.2005.035436
URL : https://hal.archives-ouvertes.fr/hal-00503869

C. Gaujoux-viala, J. Smolen, R. Landewe, M. Dougados, T. Kvien et al., Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.1004-1009, 2010.
DOI : 10.1136/ard.2009.127225

B. Kuriya, E. Arkema, V. Bykerk, and E. Keystone, Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission, Annals of the Rheumatic Diseases, vol.69, issue.7, pp.1298-1304, 2011.
DOI : 10.1136/ard.2009.118307

J. Smolen, R. Landewe, F. Breedveld, M. Dougados, P. Emery et al., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.964-975, 2011.
DOI : 10.1136/ard.2009.126532

J. Nam, K. Winthrop, R. Van-vollenhoven, K. Pavelka, G. Valesini et al., Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.976-986, 2010.
DOI : 10.1136/ard.2009.126573

M. Soubrier, X. Puechal, J. Sibilia, M. X. Meyer, O. Combe et al., Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial, Rheumatology, vol.48, issue.11, pp.1429-1434, 2009.
DOI : 10.1093/rheumatology/kep261
URL : https://hal.archives-ouvertes.fr/hal-00617943

R. Van-vollenhoven, S. Ernestam, P. Geborek, I. Petersson, L. Coster et al., Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial, The Lancet, vol.374, issue.9688, pp.459-466, 2009.
DOI : 10.1016/S0140-6736(09)60944-2

L. Moreland, O. Dell, J. Paulus, H. Curtis, J. Bathon et al., A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial, Arthritis & Rheumatism, vol.69, issue.Suppl, pp.2824-2835, 2012.
DOI : 10.1002/art.34498

A. Finckh, N. Bansback, C. Marra, A. Anis, K. Michaud et al., Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents, Annals of Internal Medicine, vol.151, issue.9, pp.612-621, 2009.
DOI : 10.7326/0003-4819-151-9-200911030-00006

G. Van-der-velde, B. Pham, M. Machado, L. Ieraci, W. Witteman et al., Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: A systematic review, Arthritis Care & Research, vol.40, issue.Suppl, pp.65-78, 2011.
DOI : 10.1002/acr.20338

N. Vastesaeger, S. Xu, D. Aletaha, S. Clair, E. Smolen et al., A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis, Rheumatology, vol.48, issue.9, pp.1114-1121, 2009.
DOI : 10.1093/rheumatology/kep155

J. Sharp, G. Bluhm, A. Brook, A. Brower, M. Corbett et al., Reproducibility of multiple-observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.31, issue.1, pp.16-24, 1985.
DOI : 10.1002/art.1780280104

J. Sharp, F. Wolfe, D. Mitchell, and D. Bloch, The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease, Arthritis & Rheumatism, vol.11, issue.6, pp.660-668, 1991.
DOI : 10.1002/art.1780340606

M. Van-den-broek, L. Dirven, A. Dehpoor, J. De-vries-bouwstra, Y. Goekoop-ruiterman et al., Eight year results of disease activity steered treatment in a large recent rheumatoid arthritis cohort: clinical and radiological outcomes, Arthritis Rheum, pp.63-157, 2011.

G. Tobon, A. Saraux, C. Lukas, F. Gandjbakhch, M. X. Combe et al., Devauchelle-Pensec V: First year radiological erosive progression is a new predictor of further erosive progression in early arthritis: results of the ESPOIR cohort, Arthritis Rheum, pp.63-874, 2011.

S. Saevarsdottir, H. Wallin, M. Seddighzadeh, S. Ernestam, P. Geborek et al., Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial, Annals of the Rheumatic Diseases, vol.70, issue.3, pp.469-475, 2011.
DOI : 10.1136/ard.2010.139212

K. Visser, Y. Goekoop-ruiterman, J. De-vries-bouwstra, H. Ronday, P. Seys et al., A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study, Annals of the Rheumatic Diseases, vol.69, issue.7, pp.1333-1337, 2010.
DOI : 10.1136/ard.2009.121160

H. Rezaei, S. Saevarsdottir, K. Forslind, K. Albertsson, H. Wallin et al., In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial, Annals of the Rheumatic Diseases, vol.71, issue.2, pp.186-191, 2011.
DOI : 10.1136/annrheumdis-2011-200038

S. Lillegraven, F. Prince, N. Shadick, E. Haavardsholm, M. Frits et al., FRI0445???The performance of matrix-based risk models for rapid radiographic progression in an observational cohort of established rheumatoid arthritis patients:, Annals of the Rheumatic Diseases, vol.71, issue.Suppl 3, p.1010, 2011.
DOI : 10.1136/annrheumdis-2012-eular.2902

B. Combe, J. Benessiano, F. Berenbaum, A. Cantagrel, J. Daures et al., The ESPOIR cohort: A ten-year follow-up of early arthritis in France, Joint Bone Spine, vol.74, issue.5, pp.440-445, 2007.
DOI : 10.1016/j.jbspin.2007.06.001

M. Prevoo, M. Van-'t-hof, H. Kuper, M. Van-leeuwen, L. Van-de-putte et al., Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.20, issue.1, pp.44-48, 1995.
DOI : 10.1002/art.1780380107

J. Fries, P. Spitz, R. Kraines, and H. Holman, Measurement of patient outcome in arthritis, Arthritis & Rheumatism, vol.33, issue.2, pp.137-145, 1980.
DOI : 10.1002/art.1780230202

D. Van-der-heijde, Joint erosions and patients with early rheumatoid arthritis, Br J Rheumatol, vol.34, pp.74-78, 1995.

D. Van-der-heijde, M. Van-leeuwen, P. Van-riel, and L. Van-de-putte, Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification), J Rheumatol, vol.22, pp.1792-1796, 1995.

A. Durnez, G. Vanderschueren, L. Lateur, R. Westhovens, and P. Verschueren, Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort, Annals of the Rheumatic Diseases, vol.70, issue.4, pp.634-637, 2011.
DOI : 10.1136/ard.2010.135319

T. Pincus, Rheumatoid Arthritis: A Medical Emergency?, Scandinavian Journal of Rheumatology, vol.5, issue.6, pp.21-30, 1994.
DOI : 10.1016/0021-9681(76)90086-2

C. Lukas, F. Guillemin, R. Landewe, D. Van-der-heijde, I. Logeart et al., Factors determining a DMARD initiation in early inflammatory arthritis patients. The ESPOIR cohort study, Clin Exp Rheumatol, vol.27, pp.84-91, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00927457

S. Saevarsdottir, K. Forslind, K. Albertsson, H. Rezaei, A. Engström et al., Development of a matrix risk model to predict rapid radiographic progression in early rheumatoid arthritis. Results from a randomized trial population, Arthritis Rheum, vol.63, p.983, 2011.

M. Soubrier, C. Lukas, J. Sibilia, B. Fautrel, F. Roux et al., Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort, Annals of the Rheumatic Diseases, vol.70, issue.4, pp.611-615, 2011.
DOI : 10.1136/ard.2010.137695
URL : https://hal.archives-ouvertes.fr/hal-00931462

L. Schipper, L. Van-hulst, R. Grol, P. Van-riel, M. Hulscher et al., Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome, Rheumatology, vol.49, issue.11, pp.2154-2164, 2010.
DOI : 10.1093/rheumatology/keq195

C. Bombardier, X. Li, P. Gregersen, D. Van-der-heijde, and M. Chen, A risk model for the prediction of radiographic progression: results from SONORA study, Arthritis Rheum, vol.61, p.276, 2009.

H. Visser, S. Le-cessie, K. Vos, F. Breedveld, and J. Hazes, How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis, Arthritis & Rheumatism, vol.302, issue.2, pp.357-365, 2002.
DOI : 10.1002/art.10117

L. Klareskog, A. Catrina, and S. Paget, Rheumatoid arthritis, The Lancet, vol.373, issue.9664, pp.659-672, 2009.
DOI : 10.1016/S0140-6736(09)60008-8
URL : https://hal.archives-ouvertes.fr/hal-01420921

L. Klareskog, P. Stolt, K. Lundberg, H. Kallberg, C. Bengtsson et al., A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA???DR (shared epitope)???restricted immune reactions to autoantigens modified by citrullination, Arthritis & Rheumatism, vol.16, issue.1, pp.38-46, 2006.
DOI : 10.1002/art.21575

S. Saevarsdottir, S. Wedren, M. Seddighzadeh, C. Bengtsson, A. Wesley et al., Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Reg, Arthritis & Rheumatism, vol.60, issue.1, pp.26-36, 2011.
DOI : 10.1002/art.27758

K. Visser, W. Katchamart, E. Loza, J. Martinez-lopez, C. Salliot et al., Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative, Annals of the Rheumatic Diseases, vol.68, issue.7, pp.1086-1093, 2009.
DOI : 10.1136/ard.2008.094474

J. Jacobs, A. Van-everdingen, S. Verstappen, and J. Bijlsma, Followup radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placebo, Arthritis & Rheumatism, vol.61, issue.5, pp.1422-1428, 2006.
DOI : 10.1002/art.21809

M. Boers, A. Verhoeven, H. Markusse, M. Van-de-laar, R. Westhovens et al., Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis, The Lancet, vol.350, issue.9074, pp.309-318, 1997.
DOI : 10.1016/S0140-6736(97)01300-7

M. Bakker, J. Jacobs, P. Welsing, S. Verstappen, J. Tekstra et al., Double-blind randomized CAMERA-II trial: better control of disease and erosive joint damage with inclusion of low-dose prednisone into a MTX-based tight control strategy for early rheumatoid arthritis, Arthritis Rheum, vol.63, p.663, 2011.

P. Emery, Evidence supporting the benefit of early intervention in rheumatoid arthritis, J Rheumatol, vol.66, pp.3-8, 2002.

R. Goldbach-mansky, J. Lee, J. Hoxworth, D. Smith, P. Duray et al., Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis, Arthritis Research, vol.2, issue.2, pp.145-153, 2000.
DOI : 10.1186/ar79